Pathology of Restrictive Lung Diseases Flashcards
restrictive lung diseases - general principles
*disorders characterized by inflammation and fibrosis of lung interstitium
*stiff lungs → reduced diffusion capacity, lung volume, lung compliance
*damage to alveolar epithelium and interstitial vasculature
*PFTs: decreased TLC, normal FEV1/FVC
major restrictive lung diseases
- idiopathic pulmonary fibrosis (IPF)
- sarcoidosis
- hypersensitivity pneumonitis
- pneumoconioses
clinical features of restrictive lung diseases
*dyspnea, tachypnea, end-inspiratory crackles
*usually no wheezing or other evidence of airway obstruction
*eventual cyanosis
*eventually, secondary pulmonary hypertension → cor pulmonale
“honeycombing” of lungs on CT scan
idiopathic pulmonary fibrosis (IPF) - overview
*clinicopathologic syndrome of unknown etiology marked by PROGRESSIVE INTERSTITIAL FIBROSIS and respiratory failure
idiopathic pulmonary fibrosis (IPF) - pathogenesis
*? repeated injury and defective repair of alveolar epithelium, leading to interstitial fibrosis
*may involve multiple cycles of lung injury, inflammation, and fibrosis
*associated with tobacco smoking, environmental pollutants, and genetic defects
idiopathic pulmonary fibrosis (IPF) - genetic alterations
*telomerase loss-of-function mutations
*mucin (MUC5B) altered production
*surfactant germline mutations
idiopathic pulmonary fibrosis (IPF) - gross morphology
*“cobblestoned” pleural surface
*firm/rubbery white fibrosis
idiopathic pulmonary fibrosis (IPF) - microscopic morphology
*patchy fibrosis
*replacement of elastin with collagen
*collapse of alveolar walls and formation of cystic spaces:
-lined by hyperplastic epithelium
-secondary pulmonary hypertension vascular changes
idiopathic pulmonary fibrosis (IPF) - diagnostic criteria
- chronic, progressive fibrotic usual interstitial pneumonia
- limited to the lung
- occurring primarily in older (>50) adults (male)
- chronic exertional dyspnea
- unknown origin
*diagnosis has substantial therapeutic/prognostic implications
*requires a multidisciplinary approach to rule out many other diseases
which pathologic changes explain the functional differences between idiopathic pulmonary fibrosis (IPF) and emphysema
*IPF: increased fibrosis
-causes rigid, dilated airspaces restricting lung expansion
*emphysema: decreased elastic fibers
-alveolar hyperexpansion due to air trapping caused by collapse of small airways upon expiration, producing obstruction
sarcoidosis - overview
*systematic disease of unknown etiology characterized by NONCASEATING GRANULOMATOUS INFLAMMATION
sarcoidosis - epidemiology
*predilection for adults younger than 40 years of age
*familial and racial clustering suggest involvement of genetic factors (incidence relatively high in Danish, Swedish, African descent)
sarcoidosis - pathogenesis
*sustained CD4+ Th1 T-cell response to unknown antigen
*local recruitment/activation of macrophages, forming NONCASEATING GRANULOMAS
*pathogenesis of pulmonary fibrosis uncertain:
-? shift from Th1 to Th2 cell cytokines
-activation of pulmonary macrophages, leading to activation of lung fibroblasts
sarcoidosis - gross morphology
*HILAR ADENOPATHY
*parenchymal scarring and honeycomb